Literature DB >> 30413910

Assessment of left atrial remodeling in paroxysmal atrial fibrillation with speckle tracking echocardiography: a study with an electrophysiological mapping system.

Yilin Chen1, Zheng Li1, Xuedong Shen1, Wei Wang1, Yu Kang1, Zhiqing Qiao1, Xinhua Wang2, Jun Pu3.   

Abstract

This study aimed to evaluate left atrial (LA) remodeling and fibrosis in paroxysmal atrial fibrillation (AF) using speckle tracking echocardiography (STE) based on the findings with radiofrequency catheter ablation (RFCA) so as to predict atrial remodeling prior to ablation. A total of 40 patients with paroxysmal AF were enrolled and divided into two groups based on LA bipolar voltage detected during RFCA: those with low-voltage zone (LVZ) (LV group, n = 19) and those without LVZ (non-LV group, n = 21). The segmental and global LA reservoir, conduit and contractile strain (εs, εe, εa) were analyzed using two-dimensional STE before RFCA. The segmental and global εs, εe, εa (%) decreased in the LV group. Especially, the εs in anteroseptal upper (18.32 ± 7.94 vs. 31.61 ± 9.39) and lower segments (16.60 ± 7.23 vs. 29.23 ± 9.81), posteroseptal upper (22.24 ± 6.65 vs. 32.23 ± 10.57) and lower segments (18.24 ± 6.49 vs. 26.40 ± 7.12), and the global εs (23.85 ± 6.74 vs. 30.48 ± 8.67) significantly decreased in the LV group than in the non-LV group (all P < 0.05). The εs ≤ 24.07 in the anteroseptal upper segment was an effective parameter to differentiate the LV group (sensitivity, 84%; specificity, 81%, P < 0.001). Besides, global εs tended to be an independent determinant of the LVZ (odds ratio 1.347, P = 0.046). STE enables a noninvasive method to evaluate LA remodeling prior ablation.

Entities:  

Keywords:  Atrial fibrillation; Left atrium; Remodeling; Speckle tracking echocardiography; Strain; Substrate

Mesh:

Year:  2018        PMID: 30413910     DOI: 10.1007/s10554-018-1470-6

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  7 in total

1.  Application of a combination of echocardiographic techniques in an experimental model of epirubicin-induced cardiotoxicity.

Authors:  Liangliang Bi; Huaxing Zhang; Ruoling Han; Wei Chen; Na Zhao
Journal:  Int J Cardiovasc Imaging       Date:  2020-02-07       Impact factor: 2.357

Review 2.  The Atrium in Atrial Fibrillation - A Clinical Review on How to Manage Atrial Fibrotic Substrates.

Authors:  Pedro Silva Cunha; Sérgio Laranjo; Jordi Heijman; Mário Martins Oliveira
Journal:  Front Cardiovasc Med       Date:  2022-07-04

3.  Clinical Utility of Left Atrial Asynchrony and Mechanical Function in Patients with Hypertrophic Cardiomyopathy.

Authors:  Ozkan Candan; Cetin Gecmen; Muzaffer Kahyaoğlu; Zeki Şimsek; Mehmet Çelik; Abdulkadir Uslu; Cevat Kirma
Journal:  Acta Cardiol Sin       Date:  2022-03       Impact factor: 2.672

4.  Recent-onset atrial fibrillation: a study exploring the elements of Virchow's triad after cardioversion.

Authors:  Panagiotis Arvanitis; Anna-Karin Johansson; Mats Frick; Helena Malmborg; Spyridon Gerovasileiou; Elna-Marie Larsson; Carina Blomström-Lundqvist
Journal:  J Interv Card Electrophysiol       Date:  2021-10-24       Impact factor: 1.759

5.  The correlation of serum long non-coding RNA ANRIL with risk factors, functional outcome, and prognosis in atrial fibrillation patients with ischemic stroke.

Authors:  Weixian Zeng; Jun Jin
Journal:  J Clin Lab Anal       Date:  2020-05-01       Impact factor: 2.352

6.  A Novel Approach for Predicting Atrial Fibrillation Recurrence After Ablation Using Deep Convolutional Neural Networks by Assessing Left Atrial Curved M-Mode Speckle-Tracking Images.

Authors:  Yi-Ting Hwang; Hui-Ling Lee; Cheng-Hui Lu; Po-Cheng Chang; Hung-Ta Wo; Hao-Tien Liu; Ming-Shien Wen; Fen-Chiung Lin; Chung-Chuan Chou
Journal:  Front Cardiovasc Med       Date:  2021-01-22

Review 7.  Clinical utility of left atrial strain in predicting atrial fibrillation recurrence after catheter ablation: An up-to-date review.

Authors:  Zhi-Xi Yu; Wen Yang; Wei-Si Yin; Ke-Xin Peng; Yi-Lin Pan; Wei-Wei Chen; Bei-Bei Du; Yu-Quan He; Ping Yang
Journal:  World J Clin Cases       Date:  2022-08-16       Impact factor: 1.534

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.